US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Alcon Inc. Ordinary Shares (NY:ALC)

63.76 -0.18 (-0.28%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Alcon Reports Second Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
US Stocks Set For Bullish Open As Analyst Shrugs Off Seasonal Lull: Here Are Key Data For Investors This Week ↗
A reversal could be in the cards Monday after the past week's lackluster showing but caution could be the undercurrent amid the uncertainties. 
Via Benzinga
News headline image
7 Top Growth Stocks to Watch for H2 2023 ↗
Many growth stocks still haven't completely recovered from their 2022 losses, so they have plenty of opportunities to do so in H2 2023. 
Via InvestorPlace
News headline image
Expert Ratings for Alcon ↗
 
Via Benzinga
News headline image
Why Lifecore Biomedical Shares Are Skyrocketing Today ↗
 
Via Benzinga
News headline image
Alcon Gets Price Target Hikes By Analysts After Q1 Results ↗
Alcon Inc. (NYSE: ALC) reported its financial results for the three months ended March 31, 2023. 
Via Benzinga
News headline image
8 Analysts Have This to Say About Alcon ↗
 
Via Benzinga
News headline image
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Alcon Advances Company’s Social Impact Through Global Volunteerism
From Alcon Inc. Corporate
Via Business Wire
News headline image
Where Alcon Stands With Analysts ↗
 
Via Benzinga
News headline image
Expert Ratings for Alcon ↗
 
Via Benzinga
News headline image
Alcon's Debt Overview ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Alcon ↗
 
Via Benzinga
News headline image
Alcon's Earnings Outlook ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗
 
Via Benzinga
News headline image
Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Keybanc raised the price target for Tempur Sealy International, Inc. (NYSE: TPX) from $48 to $50. Keybanc analyst Bradley Thomas maintained an Overweight rating. Tempur Sealy International shares rose... 
Via Benzinga
News headline image
Alcon Reports First Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
The Latest Analyst Ratings for Alcon ↗
 
Via Benzinga
This Favorable Sign Appears On Alcon's Chart ↗
 
Via Benzinga
News headline image
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Results of 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Publishes Agenda for 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon to Host 2023 Capital Markets Day
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon Reports Fourth Quarter and Full Year 2022 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
From Alcon Inc. Investors
Via Business Wire
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >